Method for treating immune complex diseases with n-acetylneuraminic acid
    1.
    发明授权
    Method for treating immune complex diseases with n-acetylneuraminic acid 失效
    用N-乙酰神经氨酸处理免疫复合物疾病的方法

    公开(公告)号:US5177062A

    公开(公告)日:1993-01-05

    申请号:US325649

    申请日:1989-03-20

    IPC分类号: A61K31/70

    CPC分类号: A61K31/7004

    摘要: A preparation for treating immune complex diseases which comprises injection containing the following compound: ##STR1## wherein when n is 1, Z represents a hydrogen, lithium, potassium, sodium, ammonium or organic ammonium, and when n is 2, Z represents calcium, barium or magnesium, as an active ingredient and pharmacologically acceptable carrier. The preparation of the present invention may be used in any administration method such as hypodermic, intramuscular and intravenous.

    摘要翻译: 一种用于治疗免疫复合物疾病的制剂,其包含含有以下化合物的注射剂:其中当n为1时,Z表示氢,锂,钾,钠,铵或有机铵,当n为2时,Z表示钙, 钡或镁,作为活性成分和药理学上可接受的载体。 本发明的制剂可以以任何施用方法如皮下注射,肌内注射和静脉内使用。

    Sialic acid derivative with active ester groups
    4.
    发明授权
    Sialic acid derivative with active ester groups 失效
    活性酸酯衍生物

    公开(公告)号:US5077397A

    公开(公告)日:1991-12-31

    申请号:US441270

    申请日:1989-11-27

    摘要: Sialic acid derivative with active ester groups expressed with the formula [I] ##STR1## Where R.sup.1 denotes hydrogen or an acetyl group, R.sup.2 denotes hydrogen or a lower alkyl group, R.sup.3 denotes C.sub.2 H.sub.4, C.sub.3 H.sub.6 or C.sub.2 H.sub.2, R.sup.4 denotes an hydroxyl group, the residue left after removing hydrogen from the alcohol portion of the active ester or alkyloxycarbonyloxy group, AC denotes an acetyl group, Ph denotes an phenyl group, and X denotes oxygen or sulfur. This sialic acid derivative has high reactivity because it has active ester groups in the molecules and can be used as a raw material or intermediate for synthesis of various sialic acid derivatives.